In vitro and in silico cytotoxicity effects of Zanthoxylum simulans Hance. fruit bark extract against gastric cancer cell lines

Year 2024, Volume: 28 Issue: 1 , 110 - 125 , 28.06.2025

Bui Thanh Tung Nguyen Thi Thuy Le Thi Huong Tran Hoang Mai Vu Manh Ha Do Thi Hong Khanh

https://izlik.org/JA92JM47BL

Abstract

Zanthoxylum simulans Hance. is known in folklore as a spicy herb, commonly used to treat cold-induced diseases in the body. In this study, we evaluated the cytotoxic effects of Zanthoxylum simulans fruit bark extract. Samples of Zanthoxylum simulans were extracted with 70% ethanol and subsequently fractionated with n-Hexane, ethyl acetate (EtOAc), and n-butanol (n-BuOH) solvents. To evaluate the in vitro cytotoxic effect, we performed SRB (Sulforhodamine B) assay on the cell lines of human gastric MKN-7. In this study, we also used molecular docking method to evaluate the inhibition abilities of MAPK1 and AKT1 receptors of 120 compounds in Zanthoxylum simulans Hance. The in vitro cytotoxic results showed that the n-Hexane total extract had the strongest cytotoxicity effects on gastric cancer cells with an IC50 of 23.65±1.75 mg/ml. The results cytotoxic effects on MNK-7 gastric cancer cells of these fractions showed that the EtOAc and EtOH fractions exhibited activity with IC50 values of 35.61±2.90 and 50.67±3.82 µg/mL, respectively; while the BuOH and H2O fractions showed no activity. The molecular docking results showed five compounds that inhibit both MAPK1 and AKT1 targets including Simulanoquinoline, N-acetylanonaine, N-acetyldehydroanonaine, Oxyavicine, and Benzosimuline. Therefore, our results showed that Zanthoxylum simulans fruit bark extract has a strong cytotoxicity effect on gastric cancer cells. In vivo studies of these potential compounds should be carried out to become anti-cancer drugs in the future.

Keywords

Zanthoxylum simulans Hance , cytotoxicity , molecular docking , gastric cancer cells , MAPK1 , AKT1

References

• [1] Meng X, Zhong J, Liu S, Murray M, Gonzalez-Angulo AM. A new hypothesis for the cancer mechanism. Cancer Metastasis Rev. 2012;31:247-268. https://doi.org/10.1007/s10555-011-9342-8
• [2] Husain S, Szabo I, Pai R, Soreghan B, Jones M, Tarnawski A. MAPK (ERK2) kinase—a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sci. 2001;69(25-26):3045-3054. https://doi.org/10.1016/S0016-5085%2808%2983299-4
• [3] Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, Jiang Y-H, Yang X-H, Liu Y-P. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis. 2009;41(12):875-880. https://doi.org/10.1016/j.dld.2009.04.006
• [4] Zhou W, Wu J, Zhu Y, Meng Z, Liu X, Liu S, Ni M, Jia S, Zhang J, Guo S. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology. BMC Complement Med Ther. 2020;20:6. https://doi.org/10.1186/s12906-019-2787-y
• [5] Han Z, Wu K, Shen H, Li C, Han S, Hong L, Shi Y, Liu N, Guo C, Xue Y, Qiao T. Akt1/protein kinase Bα is involved in gastric cancer progression and cell proliferation. Dig Dis Sci. 2008;53:1801-1810. https://doi.org/10.1007/s10620-007-9824-2
• [6] Zhou W, Fu X, Zhang L, Zhang J, Huang X, Lu X, Shen L, Liu B, Liu J, Luo H. The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells. Cell Death Dis. 2013;4(10):1-11. https://doi.org/10.1038/cddis.2013.375
• [7] Almhanna K, Strosberg J, Malafa M. Targeting AKT protein kinase in gastric cancer. Anticancer Res. 2011; 31(12): 4387-4392.
• [8] Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis. 2018;35:309-318. https://doi.org/10.1007/s10585-018-9903-0
• [9] Jain S, Dwivedi J, Jain PK, Satpathy S, Patra A. Medicinal plants for treatment of cancer: A brief review. Pharmacogn J. 2016;8(2): 87-102. https://doi.org/10.5530/pj.2016.2.1
• [10] Ombito JO. Phytochemistry and pharmacology of the genus Zanthoxylum (Rutaceae): A Review. Nat Prod J. 2021;11(1):21-43. https://doi.org/10.2174/2210315509666191202095924
• [11] Chen I-S, Wu S-J, Leu Y-L, Tsai I-W, Wu T-S. Alkaloids from root bark of Zanthoxylum simulans. Phytochemistry. 1996;42(1):217-219. https://doi.org/10.1016/0031-9422(95)00856-X
• [12] Lim T. Zanthoxylum simulans. In: Edible Medicinal And Non-Medicinal Plants, 2012, pp.904-911. http://dx.doi.org/10.1007/978-94-007-4053-2_105
• [13] Larregieu CA, Benet LZ. Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements. AAPS J. 2013;15(2):483-497. https://doi.org/10.1208/s12248-013-9456-8
• [14] Pham-The H, Cabrera-Pérez MÁ, Nam NH, Castillo-Garit JA, Rasulev B, Le-Thi-Thu H, Casañola-Martin GM. In Silico Assessment of ADME Properties: Advances in Caco-2 Cell Monolayer Permeability Modeling. Curr Top Med Chem. 2018;18(26):2209-2229. https://doi.org/10.2174/1568026619666181130140350
• [15] Wang J-F, Deng Y-H, Yang S-H, Liu Y-Q, Wang Y-H, Pan W-W, Zhou X-J. Characterization and biological evaluation of six new dimeric lignans with an unusual α, β-unsaturated ketone motif from Zanthoxylum simulans. Bioorg Med Chem Lett. 2014;24(19):4667-4471. https://doi.org/10.1016/j.bmcl.2014.08.042
• [16] Thu NB, Trung TN, Ha DT, Khoi NM, Hung TV, Hien TT, Yim N-H, Bae K-H. Screening of Vietnamese medicinal plants for cytotoxic activity. Nat Prod Sci. 2010;16(1):43-49.
• [17] Tian Y-Q, Hu D, Zhang Y-L, Zou J, Chen G-L, Guo M-Q. Inhibitors targeting multiple Janus Kinases from Zanthoxylum simulans mediate ınhibition and apoptosis against gastric cancer cells via the estrogen pathway. Front. Chem. 2022;10: 922110. https://doi.org/10.3389/fchem.2022.922110
• [18] Shwu-Jen W, Ih-Sheng CJP. Alkaloids from Zanthoxylum simulans. Phytochemistry. 1993;34(6):1659-1961. https://doi.org/10.1016/S0031-9422(00)90870-7
• [19] Maduka TO, Ikpa CB. Zanthoxylum rhetsa (Roxb.) DC.: A systemic review of its ethnomedicinal properties, phytochemistry and pharmacology. World News Nat. Sci. 2021;37:41-57.
• [20] Alam F, Najum us Saqib Q, Waheed A. Cytotoxic activity of extracts and crude saponins from Zanthoxylum armatum DC. against human breast (MCF-7, MDA-MB-468) and colorectal (Caco-2) cancer cell lines. BMC Complement Altern Med. 2017;17(1):368. https://doi.org/10.1186/s12906-017-1882-1
• [21] Chen IS, Wu SJ, Tsai IL. Chemical and bioactive constituents from Zanthoxylum simulans. J Nat Prod. 1994;57(9):1206-1211. https://doi.org/10.1021/np50111a003
• [22] Chang HS, Lee SJ, Yang CW, Chen IS. Cytotoxic sesquiterpenes from Magnolia kachirachirai. Chem Biodivers. 2010;7(11):2737-2747. https://doi.org/10.1002/cbdv.200900418
• [23] Ih-Sheng C, Shwu-Jen W, Yuh-Chwen L, Ian-Lih T, Seki H, Feng-Nien K, Che-Ming T. Dimeric 2-quinolone alkaloid and antiplatelet aggregation constituents of Zanthoxylum simulans. Phytochemistry. 1994;36(1):237-239. https://doi.org/10.1016/S0031-9422(00)97045-6
• [24] Sumary DP, Mgina CA, Joseph CC. Isolation and antimicrobial activities of a novel discolornolide and other compounds from Monanthotaxis discolor. Nat Prod Res. 2020;34(22):3163-3168. https://doi.org/10.1080/14786419.2018.1553168
• [25] Chen I-S, Tsai I-W, Teng C-M, Chen J-J, Chang Y-L, Ko F-N, Lu MC, Pezzuto JM. Pyranoquinoline alkaloids from Zanthoxylum simulans. Phytochemistry. 1997;46(3):525-529. https://doi.org/10.1016/S0031-9422(97)00280-X
• [26] Hu J, Zhang WD, Liu RH, Zhang C, Shen YH, Li HL, Liang MJ, Xu XK. Benzophenanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti‐inflammatory activities. Chem Biodivers. 2006;3(9):990-995. https://doi.org/10.1002/cbdv.200690108
• [27] Orellana EA, Kasinski AL. Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation. Bio-protocol. 2016;6(21):1-7. https://doi.org/10.21769/BioProtoc.1984
• [28] Qu Y, Yang X, Li J, Zhang S, Li S, Wang M, Zhou L, Wang Z, Lin Z, Yin Y, Liu J, Wang N, Yang Y. Network pharmacology and molecular docking study of Zhishi-Baizhu herb pair in the treatment of gastric cancer. Evid Based Complement Alternat Med. 2021; 2021:2311486. https://doi.org/10.1155/2021/2311486
• [29] Du K, Ma W, Yang C, Zhou Z, Hu S, Tian Y, Zhang H, Ma Y, Jiang X, Zhu H, Liu H, Chen P, Liu Y. Design, synthesis, and cytotoxic activities of isaindigotone derivatives as potential anti-gastric cancer agents. J Enzyme Inhib Med Chem. 2022;37(1):1212-1226. https://doi.org/10.1080/14756366.2022.2065672
• [30] Singh VJ, Sharma B, Chawla PA. Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents. Bioorg Chem. 2021; 114:105161. https://doi.org/10.1016/j.bioorg.2021.105161
• [31] Lebedev TD, Khabusheva ER, Mareeva SR, Ivanenko KA, Morozov AV, Spirin PV, Rubtsov PM, Snezhkina AV, Kudryavtseva AV, Sorokin MI, Buzdin AA, Prassolov VS. Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors. J Biol Chem. 2022;298(8): :102226. https://doi.org/10.1016/j.jbc.2022.102226
• [32] Song S, Zhou J, Li Y, Liu J, Li J, Shu P. Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix-Amomi Fructus against gastric cancer. Sci Rep. 2022;12(1):9401. https://doi.org/10.1038/s41598-022-13223-z
• [33] Gu S, Xue Y, Gao Y, Shen S, Zhang Y, Chen K, Xue S, Pan J, Tang Y, Zhu H. Mechanisms of Indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking. Sci Rep. 2020;10(1):15204. https://doi.org/10.1038/s41598-020-71030-w
• [34] Tang L, Zhang S, Ji JC, Wang PJ, Zhang M, Feng PM, Gao XL. Identifying the mechanisms of Rosa Roxburghii Tratt on treating gastric cancer: Combining the targetable screening from the cancer genome atlas with network pharmacology. Nat Prod Commun. 2021;16(11). https://doi.org/10.1177/1934578X211059646
• [35] Deyá AD. Anti-cancer properties of benzophenanthridine alkaloids from Zanthoxylum genus-in silico evidence. Rev Latinoam de Quimica. 2022 ; 26-44.
• [36] Ko FN, Chen IS, Wu SJ, Lee LG, Haung TF, Teng CM. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans. Biochim Biophys Acta. 1990;1052(3):360-365. https://doi.org/10.1016/0167-4889(90)90144-3
• [37] Yang YP, Cheng MJ, Teng CM, Chang YL, Tsai IL, Chen IS. Chemical and anti-platelet constituents from Formosan Zanthoxylum simulans. Phytochemistry. 2002;61(5):567-572. https://doi.org/10.1016/S0031-9422(02)00268-6
• [38] Li DX, Liu M, Zhou XJ. A new dimeric lignan from Zanthoxylum simulans. Zhongguo Zhong Yao Za Zhi. 2015;40(14):2843-2848.
• [39] Chyau CC, Mau JL, Wu CM. Characteristics of the steam-distilled oil and carbon dioxide extract of Zanthoxylum simulans fruits. J Agric Food Chem. 1996;44(4):1096-1099. https://doi.org/10.1021/jf950577d
• [40] Qi H, Wang WX, Dai JL, Zhu L. In vitro anthelmintic activity of Zanthoxylum simulans essential oil against Haemonchus contortus. Vet Parasitol. 2015;211(3-4):223-227. https://doi.org/10.1016/j.vetpar.2015.05.029